Open Government Portal

Suggest a Dataset

1,109 records found
  • Open Information

    Progress in Addressing Drug Shortages

    Health Canada works collaboratively with provinces and territories, as well as industry stakeholders and health care practitioners to address drug shortages and to build a more open and secure drug supply system. Important progress on a number of key initiatives has been made.
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Roles and Responsibilities to Address Drug Shortages

    The drug supply chain is highly integrated and interdependent. All stakeholders have important roles to play when it comes to addressing drug shortages.
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Notice to Interested Parties - Mandatory Notification of Drug Shortages

    Drug shortages are a complex and pressing global issue with serious implications for the health and well-being of Canadians. Sudden or prolonged disruptions in the availability of a product can have serious and/or life-threatening consequences for patients. It is only through the availability...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Information on Drug Shortages

    Notification and communication of drug shortages by drug manufacturers and importers is an essential component of preventing and mitigating shortages. Timely and public information on drug shortages can help the drug supply chain and the healthcare system respond appropriately and to minimize the...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Guide on the requirements for providing information related to drug shortages...

    Health Canada is responsible for helping the people of Canada maintain and improve their health. This is done, in part, by our commitment and actions to help protect the Canadian drug supply, thus ensuring that people in Canada have access to the drugs they need when they need them.
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Prescription status of edaravone and personal importation: Notice of update

    Organizations and the provinces/territories continue to make progress in the marketing and reimbursement of edaravone (brand name Radicava). Currently, all provinces with the exception of Prince Edward Island (PEI) have updated their drug formularies to include edaravone for public reimbursement....
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Notice: Health Canada and United States Food and Drug Administration Joint Pu...

    Health Canada and the U.S. Food and Drug Administration (FDA) are holding joint public consultation meetings on International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines currently under development. The aim of this initiative is to hold...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Notice: Release of draft revised guidance documents on Post-Notice of Complia...

    Health Canada is pleased to announce the release of five associated revised draft guidance documents on Post-Notice of Compliance (NOC) Quality Changes for pharmaceutical, biologic and radiopharmaceutical drugs for human use, for stakeholder consultation.
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Notice: Clarifications Regarding Access to Restricted Drugs through the Speci...

    Drugs are authorized for sale in Canada once they have successfully gone through the drug review process, which includes the assessment of the safety, efficacy and quality of the drug. However, Health Canada's SAP allows practitioners to request access to drugs that are not available in Canada...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Notice: Revision to the Guidance Document: Management of Drug Submissions and...

    Health Canada is revising the Guidance Document entitled: The Management of Drug Submissions and Applications (MDSA). This document provides sponsors and Health Canada staff of the Therapeutic Products Directorate, the Biologic and Radiopharmaceutical Drugs Directorate, the Natural and...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
You can also access this registry using the API (see API Docs).